ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,555.74
      -0.16%
      US Tech 100
      19,224.80
      0.00%
      Dow Jones
      40,358.09
      -0.16%
      Brent Oil
      80.605
      -0.21%
      Bitcoin
      66,024.91
      0.15%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Canada
      5. TSX

      6. HLS Therapeutics Inc (HLS) Quote

      HLS Therapeutics Inc

      HLS Therapeutics Inc (HLS)

      Healius Limited
      3.26
      -0.33
      (-9.19%)
      Closed July 24 4:12PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      3.26
      Bid
      3.26
      Ask
      3.50
      Volume
      802
      3.25 Day's Range 3.40
      3.18 52 Week Range 6.40
      Market Cap
      104.255M
      Previous Close
      3.59
      Open
      3.40
      Last Trade
      100
      @
      3.26
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      4,065
      Shares Outstanding
      31,980,000
      Dividend Yield
      -
      PE Ratio
      -3.79
      Earnings Per Share (EPS)
      -0.86
      Revenue
      63.61M
      Net Profit
      -27.53M

      About HLS Therapeutics Inc

      Sector
      Pharmaceutical Preparations
      Industry
      Motor Vehicle Part,accessory
      Website
      www.hlstherapeutics.com
      Headquarters
      Toronto, Ontario, Can
      Founded
      2018
      HLS Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the Toronto Stock Exchange with ticker HLS. The last closing price for HLS Therapeutics was $3.59. Over the last year, HLS Therapeutics shares have traded in a share price range of $ 3.18 to $ 6.40.

      HLS Therapeutics currently has 31,980,000 shares outstanding. The market capitalization of HLS Therapeutics is $114.81 million. HLS Therapeutics has a price to earnings ratio (PE ratio) of -3.79.

      HLS Latest News

      More News

      HLS Therapeutics Announces the Sale of its XENPOZYME® Royalty Interest to DRI Healthcare Trust

      HLS Therapeutics Announces the Sale of its XENPOZYME® Royalty Interest to DRI Healthcare Trust Canada NewsWire TORONTO, July 2, 2024 Total consideration of up to $45.75 million, which...

      July 02 2024
      PR Newswire (Canada)

      HLS Therapeutics Reports Annual Meeting Results

      HLS Therapeutics Reports Annual Meeting Results Canada NewsWire TORONTO, June 7, 2024 TORONTO, June 7, 2024 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS...

      June 07 2024
      PR Newswire (Canada)

      New Study Published on the Impact of Pharmaceutical Support Programs on Persistence with Clozapine Treatment

      New Study Published on the Impact of Pharmaceutical Support Programs on Persistence with Clozapine Treatment Canada NewsWire DORVAL, QC, May 28, 2024 Real world evidence demonstrates...

      May 28 2024
      PR Newswire (Canada)

      HLS Therapeutics Announces Q1 2024 Financial Results

      HLS Therapeutics Announces Q1 2024 Financial Results Canada NewsWire TORONTO, May 9, 2024 TORONTO, May 9, 2024 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX:...

      May 09 2024
      PR Newswire (Canada)

      HLS Therapeutics to Host Q1 Fiscal 2024 Financial Results Conference Call

      HLS Therapeutics to Host Q1 Fiscal 2024 Financial Results Conference Call Canada NewsWire TORONTO, April 25, 2024 TORONTO, April 25, 2024 /CNW/ - HLS Therapeutics Inc. ("HLS" or the...

      April 25 2024
      PR Newswire (Canada)

      HLS Therapeutics to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

      HLS Therapeutics to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference Canada NewsWire TORONTO, April 9, 2024 TORONTO, April 9, 2024 /CNW/ - HLS Therapeutics Inc. (HLS or...

      April 09 2024
      PR Newswire (Canada)

      New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups

      New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups Canada NewsWire TORONTO, April 8, 2024 Findings Presented...

      April 08 2024
      PR Newswire (Canada)

      HLS Therapeutics Announces Fiscal 2023 Financial Results

      HLS Therapeutics Announces Fiscal 2023 Financial Results Canada NewsWire TORONTO, March 14, 2024 TORONTO, March 14, 2024 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company"...

      March 14 2024
      PR Newswire (Canada)

      HLS Therapeutics to Host Q4 and Fiscal 2023 Financial Results Conference Call

      HLS Therapeutics to Host Q4 and Fiscal 2023 Financial Results Conference Call Canada NewsWire TORONTO, Feb. 29, 2024 TORONTO, Feb. 29, 2024 /CNW/ - HLS Therapeutics Inc. ("HLS" or the...

      February 29 2024
      PR Newswire (Canada)

      HLS Announces that Vascepa® is now reimbursed by British Columbia's Provincial Drug Plan

      HLS Announces that Vascepa® is now reimbursed by British Columbia's Provincial Drug Plan Canada NewsWire TORONTO, Feb. 6, 2024 Public reimbursement for Vascepa is now available in...

      February 06 2024
      PR Newswire (Canada)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.19-5.507246376813.453.593.1816673.35576434CS
      4-0.2-5.780346820813.463.793.1827413.46037064CS
      12-1.39-29.89247311834.654.83.1840653.68020577CS
      26-0.82-20.09803921574.085.483.1872094.00290763CS
      52-2.95-47.50402576496.216.43.1889244.2603379CS
      156-14.21-81.339439038417.4720.523.18186509.69481201CS
      260-14.99-82.136986301418.2525.913.183018814.76403928CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1629
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 63.09
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 1.57
      (0.00%)
      		0
      AACIArmada Acquisition Corporation I
      $ 11.30
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.674
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1629
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 63.09
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 1.57
      (0.00%)
      		0
      AACIArmada Acquisition Corporation I
      $ 11.30
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.674
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1629
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 63.09
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 1.57
      (0.00%)
      		0
      AACIArmada Acquisition Corporation I
      $ 11.30
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.674
      (0.00%)
      		0

      Discussion

      View Full Feed
      Margin Buu Margin Buu 1 minute ago
      Thanks for pointing out Leg-ends hypocrisy. He’s a spreader of FUD and not very good at it.
      NWBO
      Jack Torrance Jack Torrance 4 minutes ago
      I personally think 80%.
      MNMD
      CaptainObvious CaptainObvious 8 minutes ago
      "The reality about this stock is nobody knows anything....

      ...something I will bet a lot on is that the stock will not get above $1"
      NWBO
      Capt_Smith77 Capt_Smith77 32 minutes ago
      I'll believe in their backing of G42 when it doesn't amount to diluting shareholders, and there's an actual appreciation in the stock price. To date, the company's financing has done nothing but reduce shareholder value.

      Now on a more positive note, at least we haven't seen any recen
      VRSSF
      tedgoeseast tedgoeseast 50 minutes ago
      Everyone else has already seen this on the news today it's nothing new
      Sonar Sonar 55 minutes ago
      The only document related to Mr Norward and Oceanwide Plaza:
      https://www.myvisajobs.com/Visa-Sponsor/Tohigh-Construction-Investment/1236463.htm
      Relationship between Mr Norward and ESSGCorp.net
      https://investorshub.advfn.com/uimage/uploads/2024/7/24/wzxfcScreenshot_2024-07-24_094
      JBZY
      Capt_Smith77 Capt_Smith77 56 minutes ago
      Of course they're not still testing the software. At least not anyone but maybe Blue Yonder, which was the last one to join the Beta program, IIRC.

      Still, the company has advertised them all as partnerships, which they are not. They've even reworded how things are said in recent PRs
      VRSSF
      snow snow 58 minutes ago
      lishious It is usually a trade-off I think. By raising prices a company will usually sell less but may even so make more money in some cases. Long-term it may or may not be a good idea to just have a very slim profit margin if that makes it possible to increase sales fast. It all depends on the circ
      IQST
      Methinks Methinks 60 minutes ago
      Kamala has a distinct advantage over Trump because she is bi-continental. The genes of people from different continents are slightly different and when these different people have children, it seems that the best genes are often used in the offspring creating very clever people. Obama was the same a
      snow snow 1 hour ago
      quigley We could not disagree more! Time will show who is closest to the truth.
      IQST
      littlejohn littlejohn 1 hour ago
      Typhoon Gaemi forecast track is for Wednesday

      pm landfall of about 6 PM EST...U.S...

      which is about 12 AM GMT on Thursday

      in Taiwan...

      https://www.worldtimebuddy.com/

      https://www.google.com/maps/@24.655501,119.6369319,7z/data
      The Danish Dude The Danish Dude 1 hour ago
      Due diligence on Ihub these days seems to be a western by John Ford

      😂
      NWBO
      pickthemright pickthemright 1 hour ago
      No he means you !
      ALPP
      Wise Man Wise Man 1 hour ago
      The ultimate dividend rate on the cumulative SPS has yet to be assessed.
      Presumably, the terms and conditions of the original UST backup of the enterprises will prevail, as part of the Charter-dynamics, "at a rate that takes into consideration the Treasury yields as of the end of the month pr
      FNMA
      spahibiscusindia spahibiscusindia 1 hour ago
      Thank you for this information. I am sharing a https://www.spahibiscusindia.com/ luxury spa service in India .
      SPTY
      snow snow 2 hours ago
      RD What does the following mean? "Apparently the amount is pending in the BoA account?" If there is just another delay of 5 days or so that is peanuts compared with a delay in your and other employees` remuneration of more than a year.
      ITUP
      nickmerck nickmerck 2 hours ago
      sector rotation. wait for EWI to level out, then we'll be in free-fall again :)
      RCAT
      jeunke22 jeunke22 2 hours ago
      Very encouraging to see that our new Board Member ( please remember that Lebby was boardmember before being appointed to the Executive Team) Yves LeMaitre is receiving congratulations from reputable industry leaders from Tier 1 companies to his new appointment. Having a great network and being recog
      LWLG
      lodas lodas 2 hours ago
      yo ron???.....do you have anymore updates on that well documented Duel Track D.C. case where WMI was awarded 309 billion dollars by Judge Collyer for RICO damages against WMI??....I kind of lost track of the message you might have posted to verify your assertion.... TIA..... Lodas
      COOP
      bwrbad bwrbad 2 hours ago
      interesting
      https://finance.yahoo.com/news/7-quantum-computing-stocks-could-112500343.html
      RGTI
      The ELTP King The ELTP King 2 hours ago
      Purdue Pharma L.P. et al v. Accord Healthcare Inc. et al

      July 23, 2024
      -Notice of Appearance filed by Gavin B. Parsons on behalf of All Defendants. (Parsons, Gavin)
      -Notice of Appearance filed by William Gabriel Pagan on behalf of All Defendants. (Pagan, William)
      ELTP

      Your Recent History

      TSX
      HLS
      HLS Therapeutics
      LSE
      AGOL
      Ashmore Global Opportuni...
      Delayed Upgrade Clock